Targeted gene therapy has shown promise for treating rare diseases, particularly those that arise from single-gene defects.
This application note from ACD demonstrates how RNAscope ISH technology and Professional Assay Services can provide morphology-based, cell-specific quantification of adeno-associated virus vector DNA and therapeutic transgene mRNA expression within intact tissue, addressing questions on biodistribution, persistence, cellular tropism, and vector promotor activity.
Offered Free by: ACD
See All Resources from: ACD
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.